Pandemic flu vaccines: New potency assay could shave weeks off the timeline
by Press Release from Outbreak News Today on (#3GHHB)
InDevR, a Boulder-based analytical technology and life science company, this week announced that it has expanded its VaxArray(R) product portfolio with a new reagent kit to address the "need for speed" in combating flu viruses with pandemic potential. The VaxArray Influenza Pandemic Hemagglutinin potency test kit is now available for flu vaccines containing H5, H7, ["]
The post Pandemic flu vaccines: New potency assay could shave weeks off the timeline appeared first on Outbreak News Today.